Non-pharmacologic management of sleep disturbance in Alzheimer's disease
- PMID: 20191254
- DOI: 10.1007/s12603-010-0050-9
Non-pharmacologic management of sleep disturbance in Alzheimer's disease
Abstract
Sleep and wake in Alzheimer's disease (AD) are often fragmented as manifested by bouts of wakefulness at night and napping during the day. Management of sleep disturbances in AD is important because of their negative impact on both patients and caregivers. Pharmacological treatments, mainly sedative-hypnotics and antipsychotics, are often used but can be associated with significant adverse effects. Non-pharmacological treatments represent a beneficial alternative approach to the management of sleep disturbances in AD since they are associated with fewer adverse effects and their efficacy can be sustained after treatment has been completed. The aim of this article is to review non-pharmacological treatments, such as sleep hygiene, sleep restriction therapy (SRT), cognitive behavioral therapy (CBT), light therapy, and continuous positive airway pressure (CPAP), for the management of sleep/wake disturbances in AD.
Similar articles
-
Sleep disorders in Alzheimer's disease and other dementias.Clin Cornerstone. 2004;6 Suppl 1A:S16-28. doi: 10.1016/s1098-3597(04)90014-2. Clin Cornerstone. 2004. PMID: 15259536 Review.
-
Sleep in older adults with Alzheimer's disease.J Neurosci Nurs. 2010 Aug;42(4):190-8; quiz 199-200. doi: 10.1097/jnn.0b013e3181e26b1d. J Neurosci Nurs. 2010. PMID: 20804113
-
Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances.Pharmacology. 2015;96(3-4):155-62. doi: 10.1159/000435889. Epub 2015 Aug 8. Pharmacology. 2015. PMID: 26279176 Clinical Trial.
-
Outpatient treatment of sleep disorders in Alzheimer patients.Einstein (Sao Paulo). 2015 Jul-Sep;13(3):430-4. doi: 10.1590/S1679-45082015RW3021. Epub 2015 May 1. Einstein (Sao Paulo). 2015. PMID: 25946052 Free PMC article. Review.
-
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.Sleep. 2003 Nov 1;26(7):893-901. doi: 10.1093/sleep/26.7.893. Sleep. 2003. PMID: 14655926 Free PMC article. Clinical Trial.
Cited by
-
Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.J Alzheimers Dis. 2022;86(1):83-109. doi: 10.3233/JAD-215324. J Alzheimers Dis. 2022. PMID: 35001893 Free PMC article. Review.
-
Neuropsychiatric symptoms in Alzheimer's disease.Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410. Alzheimers Dement. 2011. PMID: 21889116 Free PMC article.
-
Non-pharmacological interventions for sleep disturbances in people with dementia.Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD011881. doi: 10.1002/14651858.CD011881.pub2. Cochrane Database Syst Rev. 2023. PMID: 36594432 Free PMC article.
-
Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review.Heliyon. 2024 Dec 24;11(1):e41445. doi: 10.1016/j.heliyon.2024.e41445. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39850411 Free PMC article. Review.
-
The Therapeutic Potential of Glymphatic System Activity to Reduce the Pathogenic Accumulation of Cytotoxic Proteins in Alzheimer's Disease.Int J Mol Sci. 2025 Aug 5;26(15):7552. doi: 10.3390/ijms26157552. Int J Mol Sci. 2025. PMID: 40806679 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical